Bukwang files patent application for new clevudine agent

Published: 2009-05-28 06:56:00
Updated: 2009-05-28 06:56:00
Bukwang has recently filed its patent application for new clevudine combination preparation, with an aim to prevent drug-resistance problem and maximize the therapeutic effects.

New combination product contains clevudine and adefovir dipivoxil.

Bukwang will work to develop this new combinat...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.